Skip to main content
. 2017 Jun 10;26(17):1000–1008. doi: 10.1089/ars.2016.6809

FIG. 4.

FIG. 4.

The principal source of a high and sustained level of NO is the NOS2. However, NO produced by NOS2 and NOS3 is implicated in pancreatic cancer progression. NO signaling is reported to have both pro- and antitumorigenic functions. Further mechanistic, functional, preclinical, and clinical studies are warranted to guide the potential therapeutic benefits of NO-based or NO-targeted treatment strategies. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars